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and routine surgeries will become inherently risky1. By
2050 more people may die of drug-resistant infections
(DRIs) every year than of cancer, which equates to more
than10million annual deaths globally2 and theWorldBank
has estimated that AMR could cost the global economy $1
trillioneveryyearafter2030.DRIsalso lead toan increase in
the length of hospital stays, the use of more toxic or costly
antibiotics and an increased likelihood of death3. BRIC
nations (Brazil, Russia, India, China) and socio-economi-
cally challenged countries and people who already have
higher rates of infectious diseases will feel the greatest
impact2. Indeed, AMR has been likened to the 2008 global
financialcrisisonanannual repeatcycle.That isbecausethe
effects of AMR are not just confined to the human medical
sector. The veterinary sector is also reliant on the availabil-
ity of antimicrobials to treat infectious diseases in compan-
ion and food-producing animals.
The level of concern around AMR was reflected at the United
Nations General Assembly in September 2016. In early 2018, the
World Health Organization (WHO), the Food and Agricultural
Organization of the United Nations (FAO) and the World Organi-
sation for Animal Health (OIE), signed a Memorandum of Under-
standing4 to stepup joint action tocombathealth threats associated
with interactions between humans, animals and the environment
with a strong focus on AMR. This approach is termed One Health
because it recognises that the health of people, animals and the
environment is intimately connected. From a climate perspective,
higher than average temperatures can exacerbate AMR as patho-
gens expand into new regions. Similarly, extreme weather events
suchasfloodinganddroughts,which impede sanitationefforts, can
increase its spread.
Globally, there has been a surge of action to reduce the threat of
AMR. This includes new schemes and funds to incentivise the
development of new antibiotics and public and health sector
campaigns that aim to reduce unnecessary and inappropriate
prescribing of antimicrobials in the human and veterinary sector.
Bacteria are consummate travellers and are extremely adept at
passing on their genetic ‘cargo’ containing genes that confer
antibiotic resistance to other bacteria. We know very little about
the levels of circulatingdrug resistance inwater ornon-humanAMR
reservoirs, thus knowing what, where and when to apply potential
solutions is part of the challenge in tackling AMR. It is understood,
however, that the information is country-specific and dynamic: it
will change from year to year, vary across a region and is inevitably
increasing.
Regions north and west of Australia including Indonesia, China,
Russia, Africa, India andSouth andEast Asiamorebroadly, aswell as
regions within South America, are recognised hotspots where
mortalities and morbidities are expected to be greatest2. From a
geographic standpoint, Australia, perhaps more than anywhere
else, has an opportunity to introduce a robust, state-of-the-art
genomic surveillance system for tracing and tracking AMR and
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pathogen evolution from a One Health perspective. As an island
nation with globally recognised biosecurity and modern antimi-
crobial stewardship practices that cannot be introduced retrospec-
tively in other regions, it is anticipated that sophisticated
surveillance will offer significant savings to our burgeoning health-
care budget – expected to hit 15%GDP by 20405 –well in excess of
the cost of its set up and ongoing maintenance.
To date, the lens applied to AMR has focussed on pathogenic
bacteria found in hospitals and healthcare facilities. But buried
beneath, at a much higher resolution, is a need to understand the
genetic vectors that purvey AMR genes (ARGs) and virulence genes
without the separation between disease-causing and commensal
bacteria. This bacterial ‘community’ level understanding can then
be overlaid onto the broader picture that considers interlinked
environmental compartments in their broadest sense including
human and animal gut microbiomes, rivers, soils, wastewater, and
so on (Figure 1).
ARGs are located either chromosomally or extra-chromosomally
and may be associated with mobile genetic elements such as
plasmids, integrons, gene cassettes, insertion sequences, or trans-
posons. These are the vehicles that enable vertical and horizontal
gene transmission (HGT) allowing susceptible bacterial strains to
become resistant6. Collectively this is referred to as the mobile
‘resistome’7.Knowingwhichbacteriapossess a resistome(intrinsic
and mobile) is therefore key to a comprehensive, robust and
scientifically-defensible AMR surveillance system and to the devel-
opment of new mitigation strategies.
A recent analysis of the mobile resistome in more than 23 000
bacterial genomes showed that mobile ARGs are predominantly
carried by four bacterial phyla (Proteobacteria, Firmicutes, Bacter-
oidetes and Actinobacteria). The greatest concentration of ARGs
localise within the Proteobacteria, the group that contains Gram
negative genera that includes Escherichia, Salmonella, Vibrio,
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Figure 1. One Health system diagram showing the spread of AMR.
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phylogeny, ecological barriers, although poorly understood, influ-
ence how mobile elements move and where they reside7.
AMR is not a new nor a man-made phenomenon. Our clinically
important antibiotics are largely derived from natural compounds
and, as such, bacteria have evolved to survive in their presence. The
advent of large scale manufacturing of pharmaceuticals and their
widespread use in medicine, veterinary practice and intensive
agricultural settings has exponentially increased the selection
pressure whereby all bacteria – commensals and pathogens – are
more likely to possess ARGs.
A significant proportion of antibiotics are excreted unmetabolised
into the environment and many will make it past our sewage
treatment plants and into our waterways. This has ramifications
for safe fresh food production, which can also be adversely affected
by the use of organic fertilisers on farmland8. Selection pressures
afforded by antimicrobial residues from industrial, agricultural and
wastewater sources enable the amplification, maintenance and
spreadof antibiotic-resistant bacteria andARGs. Active stewardship
in all sectors is needed to avoid gene flow to and from environ-
mental resistance reservoirs but while antimicrobial stewardship
will delay and confine AMR, indirect selection and cross resistance
can still occur. Resistance mechanisms to biocides and heavy
metals, such as copper and zinc which are used as non-antibiotic
growth promoters in intensive animal industries9,10 and in other
settings, may be present on the same genetic elements as those
conferring resistance to antibiotics.
Perhaps of greater concern is the high frequency of insertion
sequences such as IS26, that are remarkable in their ability to
capture, mobilise and shape the resistance gene cargo11,12 – they
are primed to pick up ARGs, which includes clinically-relevant
antibiotics. The behaviour of IS26may influence the overall fitness
impost afforded to the bacterial hosts that carry these elements by
inadvertently deleting DNA sequences in the core plasmid back-
bone that influence fitness13.
One of the biggest gaps in knowledge is quantifying carriage and
long-term maintenance of AMR in the gut of healthy humans.
Carriage rates are influenced by contact and consumption of water,
antimicrobials, and food and the environmentmore broadly, which
includeswildlife andcompanionanimals.E. coli is amodelorganism
that colonises a range of environments, can be considered a com-
mensalorpathogen inall vertebrates, and is thereforewidelyusedas
an indicator of faecal contamination in municipal water supplies.
HGT has enabled E. coli to evolve both as an intestinal and an
extraintestinal pathogen and both clades have acquired resistance
tomultiple antibiotics.Ourwhole genome sequencinghas enabled
us to understand ARG carriage in commensal and pathogenic
E. coli populations in swine, poultry and humans and how itmoves
between these reservoirs. Antibiotic residues also act as an AMR
selection pressure in wildlife populations that cohabit regions
where anthropogenic activities are high.
More recently, E. coli from the gastrointestinal tracts of 40 per cent
(80 birds) of the sampled silver gull populations nesting on Five
Islands near Wollongong in NSW were found to carry E. coli
containing a carbapenem resistance gene. Specifically, blaIMP-4,
foundwithin the cassette array blaIMP-4-qacG-aacA4-catB3 of class
1 integrons, was detected in phylogenetically diverse E. coli that
share many features with E. coli from humans causing serious
infections inAustralianhospitals. These studies showthat theuseof
antibiotics canhave a significant impact on the environment andon
wild animals14.While this is a significant example of transmission of
ARGs with local relevance, it highlights the universal challenges of
controlling and curtailing the impact of AMR.
In this era of globalisation, Australia needs technologies that will
enable us to adapt and minimise the unprecedented risk of
AMR. Fortunately, we have the technology to be a leader in One
HealthsurveillanceofAMR.This approachwill helpus tomakedata-
driven decisions around targeted antibiotic use (in livestock and
people), outbreak risk (including the source of infection), and
assist us to get a handle on emerging resistance via known and
(currently) unknown mechanisms.
The UN Interagency Coordination Group on Antimicrobial Resis-
tance (IACG; includes the WHO, the FAO and the OIE) is in the
process of formulating its final recommendations to ensure the
world’s leading organisations address the threat of AMR. This will
feed into the UN Secretary General’s report that is due in Septem-
ber 2019. The report will aim to provide practical guidance for
better coordination effective global actions. It won’t be a moment
too soon.
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